ClariClear Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Adverse Reactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Oxymetazoline HCl

Indications/Uses

Symptomatic relief of nasal & nasopharyngeal congestion. Facilitates intranasal exam or before nasal surgery.

Click to view ClariClear detailed prescribing information

Dosage/Direction for Use

2-3 sprays bd into each nostril.

Click to view ClariClear detailed prescribing information

Contraindications

Idiosyncrasies to sympathomimetics; hyperthyroidism; HTN, coronary disease.

Click to view ClariClear detailed prescribing information

Special Precautions

Cardiac disease; DM. Chronic nasal congestion upon w/drawal (prolonged use). Concurrent administration w/ MAOI.

Click to view ClariClear detailed prescribing information

Adverse Reactions

Occasionally, burning sensation in nose/throat, local irritation, nausea, headache, nasal mucosa dryness. Rebound nasal congestion (prolonged use). Apnoea & instant collapse in infants.

Click to view ClariClear detailed prescribing information

Drug Interactions

Enhanced pressor effects by MAOI. Reversed action of antihypertensives.

Storage

View ClariClear storage conditions for details to ensure optimal shelf-life.

Description

View ClariClear description for details of the chemical structure and excipients (inactive components).

Action

View ClariClear mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Nasal Decongestants & Other Nasal Preparations

ATC Classification

R01AA05 - oxymetazoline ; Belongs to the class of topical sympathomimetic agents used as nasal decongestants.

Regulatory Classification

Presentation/Packing

Form

ClariClear nasal spray 0.05%

Packing/Price

15 mL x 1's

ClariClear

oxymetazoline

Manufacturer:

Bayer

Distributor:

Zuellig Pharma